Intestinal Atresia: Clinical Trials

1 trial for Intestinal Atresia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Intestinal Atresia: new trials by email Literature Review of Intestinal Atresia trials Research Report on Intestinal Atresia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome
Phase 1 / Phase 2TerminatedAlberta Children's Hospital132012-01-012014-12-23

Narrower conditions

Enterocolitis, Necrotizing (1)  ·  Gastroschisis (1)  ·  Infant Nutrition Disorders (1)  ·  Intestinal Failure (1)  ·  Malnutrition (1)  ·  Short Bowel Syndrome (1)

Broader conditions

Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Enterocolitis (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Hernia (1)  ·  Hernia, Abdominal (1)  ·  Intestinal Diseases (1)  ·  Malabsorption Syndromes (1)  ·  Musculoskeletal Abnormalities (1)  ·  Musculoskeletal Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Glucagon-Like Peptide 2 (1)

Sponsors

Alberta Children's Hospital (1)

Countries

Canada (1)

Top investigators

David Sigalet, MD PhD (1)